Join to View Full Profile
300 Pasteur DrPalo Alto, CA 94305
Phone+1 650-723-4000
Dr. Annes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2004 - 2009
New York University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2012 - 2026
MA State Medical License 2006 - 2013
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics.Ella A Thomson, Sooyeon Lee, Haixia Xu, Hannah Moeller, Joanna Sands
Diabetes. 2025-02-28 - c.1155-3A>G is a pathogenic variant that causes aberrant splicing, disrupted parafibromin expression, and hyperparathyroidism-jaw tumor syndrome.Leor Needleman, Nicolette Chun, Sathvika Sitaraman, Marilyn Tan, Deborah E Sellmeyer
JBMR Plus. 2025-01-01 - Author Correction: Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase.Shane M O'Carroll, Christian G Peace, Juliana E Toller-Kawahisa, Yukun Min, Alexander Hooftman
Nature Metabolism. 2025-01-01
Press Mentions
Protocol for Determining Zinc-Dependent Β Cell-Selective Small-Molecule Delivery in Mouse PancreasJanuary 12th, 2021
Zinc Chelation May Be Able to Deliver Drug to Insulin-Producing CellsDecember 11th, 2018- Researchers Use Zinc to Target Insulin-Producing Cells with Regenerative DrugDecember 6th, 2018
- Join now to see all
Grant Support
- Diabetes, Endocrinology and Metabolism Training GrantSTANFORD UNIVERSITY1976–2028
- Diabetes, Endocrinology and Metabolism Training GrantSTANFORD UNIVERSITY1976–2028
- Diabetes, Endocrinology and Metabolism Training GrantSTANFORD UNIVERSITY1976–2028
- Developing A Platform Technology For β-Cell-Targeted Drug DeliverySTANFORD UNIVERSITY2023–2025
- Leveraging the Uniquely High Beta-Cell Zinc Content for Targeted Drug DeliverySTANFORD UNIVERSITY2015–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
